Intravenous infusion pumps market seen nearing $10 billion by 2030

The intravenous infusion pumps market is projected to grow from $6.98 billion in 2026 to $9.98 billion by 2030, driven by demand for smart, interoperable devices and more home-based care. North America held the largest regional share in 2025 as bleeding disorders and chronic disease treatment continue to support demand.

Why it matters: - Intravenous infusion pumps are central to precise delivery of fluids, medications and nutrients, making them important in both critical care and routine treatment. - The market’s growth points to rising demand for safer, more connected drug delivery systems as healthcare shifts toward patient-centric and home-based care. - Expanded use of infusion pumps can affect hospital workflows, medication safety and access to therapy for patients with long-term conditions.

What happened: - The Business Research Company projected the global intravenous infusion pumps market will rise from $6.37 billion in 2025 to $6.98 billion in 2026. - The report forecasts the market will reach $9.98 billion by 2030. - The report was released Aug. 13, 2026, from London. - The company published the analysis in its Intravenous Infusion Pumps Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - A free sample report is available here. - The full report is available here.

The details: - The market is expected to grow at a 9.5% compound annual growth rate in 2026 and a 9.4% CAGR through 2030. - Recent growth came from hospital expansion, broader use of intravenous drug delivery, rising chronic illness rates, programmable infusion systems and better pump precision and reliability. - Future growth is expected to come from interoperable infusion devices, patient-centric care models, remote patient monitoring, smart healthcare infrastructure and home-based infusion therapies. - Key trends include wider use of smart infusion pumps, dose error reduction software, connected hospital systems, ambulatory and home infusion services, and a stronger focus on medication safety. - Intravenous infusion pumps are designed to administer fluids, medications or nutrients directly into a patient’s bloodstream with high accuracy and consistency. - The devices support steady dosing in critical care and routine treatment.

Between the lines: - Bleeding disorders are a major demand driver because they require precise and reliable medication delivery. - The report links this demand to genetic causes and higher rates of consanguineous marriages, which can increase inherited clotting deficiencies. - Pfizer reported in April 2025 that more than 11,800 people in the United Kingdom were living with haemophilia A or B in 2023-2024. - Pfizer also said more than 800,000 people globally are affected by haemophilia, which is usually diagnosed in early childhood. - North America held the largest regional share in 2025, with Western Europe in second place. - The report also covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa.

What's next: - The market outlook points to continued investment in smart infusion technology and connected hospital systems. - Home infusion and ambulatory services are likely to keep expanding as care shifts away from the hospital. - The Business Research Company said its 2026 reports also include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspot infographics and updated trend graphics.

The bottom line: - Infusion pumps are moving from basic delivery tools to connected, safety-focused systems, and that shift is expected to keep the market growing through 2030.